Christopher Zahn
Dr. Christopher Zahn is the chief of clinical practice for the American College of Obstetricians and Gynecologists, where he emphasizes the importance of judicious use of acetaminophen during pregnancy, advocating for patient safety while addressing the complexities surrounding neurodevelopmental disorders.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United States | 2 | 5.50 | 0.08% | +10% | 331,002,651 | 288,627 | $21,000,000 | 18,312$ |
| Canada | 1 | 5.00 | 0.08% | +0% | 38,005,238 | 29,831 | $1,700,000 | 1,334$ |
| United Kingdom | 1 | 5.00 | 0.04% | +0% | 67,886,011 | 29,274 | $2,700,000 | 1,164$ |
| Totals | 4 | 436,893,900 | 347,732 | $25,400,000 | 20,810$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Dr. Christopher Zahn emphasized that neurodevelopmental disorders are multifactorial and difficult to associate with a singular cause.
5
Canada:
Christopher Zahn, chief of clinical practice for the American College of Obstetricians and Gynecologists, stated there is no clear evidence that proves a direct relationship between the prudent use of acetaminophen during pregnancy and fetal developmental issues.
5
United Kingdom:
Christopher Zahn is the chief of clinical practice at the American College of Obstetricians and Gynecologists who stated there is no clear evidence linking acetaminophen use during pregnancy to fetal developmental issues.
5
United States:
Dr. Christopher Zahn, chief of clinical practice for the American College of Obstetricians and Gynecologists, stated that there is no clear evidence linking acetaminophen use during pregnancy to fetal developmental issues.
6